Neck and trapezius myofascial pain · Randomized trial · 2012
Does low-energy shockwave ease upper-shoulder muscle pain?
In this trial, four sessions of focused shockwave over two weeks lowered pain on pressing the sore spot from about 5 to about 2 out of 10. With a very-low-energy sham, it went from about 5 to just over 4. People could also bear firmer pressure after shockwave.
Helped more than a very-low-energy sham- adults with upper-shoulder muscle pain
- 22
- sessions, twice a week
- 4
- weeks of treatment, checked right after
- 2
Good to know: No one had medicine, physio or exercise for the pain during the study.
Ji HM, Kim HJ, Han SJ Annals of Rehabilitation Medicine, 2012 · Read the paper ↗
How this study worked
What happened
Pain when the sore spot is pressed
0–10 pain scale · start and right after the fourth session
StartAfter 4 sessions
Show the numbers
| Group | People | Start | After 4 sessions |
|---|---|---|---|
| Shockwave | 9 | 4.91 | 2.27 |
| Very-low-energy sham | 11 | 4.89 | 4.44 |
The treatment
Shockwave
Focused, twice a week for 2 weeks
- Sessions
- 4, two a week
- Pulses
- 700 per point · on the tight band, plus 300 around it
- Strength
- 0.056mJ/mm²
- Numbing
- Not mentioned
- Device
- Dornier AR2
Compared with: A sham with very low energy (0.001 mJ/mm²), with sound to keep it convincing
Settings are what each study used, not a prescription.
Who took part
22 adults with muscle pain and tight, tender bands in the upper trapezius (the muscle on top of the shoulder). Of the 20 analysed (aged 25 to 74), 17 were women.
hollow squares: no final score
Side effects
No one stopped because of side effects.
All the numbers and the full appraisal
The results, in numbers.
Adults with upper-trapezius myofascial pain syndrome; 22 recruited and 20 analyzed (9 treated, 11 control), ages 25–74 years, 3 men and 17 women among analyzed participants.
Eleven participants were assigned to this arm; two withdrew for geographic access, leaving nine analyzed.
Eleven participants were assigned to this arm; all eleven were analyzed.
Pain at pressure threshold, 10-cm visual analogue scale1 reported outcome
Pain at pressure threshold, 10-cm visual analogue scale
Visual analogue scale (VAS), 10 cm VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Low-energy focused ESWT | 9 | 4.91 (SD 1.76) | 2.27 (SD 1.27) |
| Very-low-energy sham-like control | 11 | 4.89 (SD 1.76) | 4.44 (SD 2.13) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Between-group comparison immediately after session four
Mann–Whitney test
Authors report a statistically significant between-group difference after treatment (p<0.05), without exact p-value or effect estimate.
Analysis details and source
Baseline and follow-up means reported. Within-group treated change was significant and control change nonsignificant by Wilcoxon (p<0.05 reported for treated); this is distinct from the between-group test. The control baseline VAS is inconsistent in the source: 4.88 in the Results paragraph ‘Distribution of age and sex’ and 4.89 (printed twice) in the next paragraph, ‘A change of pain before and after the therapy’; the abstract gives no control value. The displayed value follows the later paragraph (4.89).
Pressure-pain threshold1 reported outcome
Pressure-pain threshold
Digital algometer N
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Low-energy focused ESWT | 9 | 40.36 (SD 9.94) | 61.2 (SD 12.16) |
| Very-low-energy sham-like control | 11 | 43.67 (SD 10.27) | 45 (SD 9.17) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Between-group comparison immediately after session four
Mann–Whitney test
Authors report a statistically significant between-group difference after treatment (p<0.05), without exact p-value or effect estimate.
Analysis details and source
Baseline and follow-up means reported. Within-group treated change was significant and control change nonsignificant by Wilcoxon (p<0.05 reported for treated); this is distinct from the between-group test.
How treatment was delivered
Dornier AR2 electromagnetic focused shock-wave generator with cylindrical coil and parabolic reflector.
0.056 mJ/mm²; 700 impulses on taut band and 300 around it.
0.001 mJ/mm², described by authors as ineffective; sound used to help maintain participant blinding.
Four sessions, twice weekly for two weeks. No medication, physiotherapy or exercise for myofascial pain during the study.
No local anesthesia reported.
Two treated participants withdrew for geographic access, not side effects. Authors report no withdrawals due to therapy side effects; systematic adverse-event counts are not presented.
Sex imbalance and limited age distribution among the 20 participants analyzed.
Single-blind design; examiner knew allocation.
Disease duration not collected; measurements only before and immediately after session four. Durability is unknown.
Table 1 is an image in raw XML and unavailable for visual inspection. Numeric values were taken from narrative text; image-only data were not inferred.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Sex imbalance and limited age distribution among the 20 participants analyzed.
- Single-blind design; examiner knew allocation.
- Disease duration not collected; measurements only before and immediately after session four. Durability is unknown.
- Table 1 is an image in raw XML and unavailable for visual inspection. Numeric values were taken from narrative text; image-only data were not inferred.
Source-linked critical reading
Randomized comparative clinical trial
Technical source record
Complete article XML, all nine section records, Table 1 caption and Figure 1–2 captions reviewed. Raw XML confirms Table 1 is embedded as an image, not a structured table. Image assets were unavailable; numeric outcomes and arm characteristics come only from the article narrative.
One study found lower pain ratings and higher pressure-pain thresholds immediately after four sessions compared with a very-low-energy control. It does not show how long changes last or whether daily function improves.
In adults with upper-trapezius myofascial pain syndrome, does low-energy focused extracorporeal shock-wave therapy change pain intensity and pressure-pain threshold compared with a very-low-energy control?
Single-blind randomized controlled study. Twenty-two patients were recruited; 20 were analyzed after two participants in the treated group withdrew for geographic-access reasons.
Participants had shoulder pain and myofascial pain syndrome diagnosed using Simon’s criteria. The analyzed sample was 20: 9 treated and 11 control; 3 men and 17 women, ages 25–74 years (overall mean 33.35, SD 12.25). The source inconsistently reports control baseline VAS as 4.88 in the first Results subsection and 4.89 in the second (the abstract gives no control value); 4.89 is retained in the displayed data. Table 1 was image-only and its cells could not be verified.
A Dornier AR2 electromagnetic focused device was used. The treated group received 0.056 mJ/mm², 700 impulses on the taut band and 300 around it, for four sessions (twice weekly for two weeks). No other myofascial-pain treatment was allowed. The control received 0.001 mJ/mm², described as ineffective but with sound intended to preserve blinding.
Very-low-energy ESWT (0.001 mJ/mm²), described as a sham-like control. There was no separate usual-care or no-treatment arm.
Pain was assessed on a 10-cm VAS anchored 0 (no pain) to 10 (maximum unbearable pain). Pressure-pain threshold was measured with an algometer in newtons; three measurements 10 seconds apart were averaged. Measures were taken before the first session and immediately after session four.
At baseline, VAS was 4.91±1.76 (treated, n=9) and 4.89±1.76 (control, n=11); pressure threshold was 40.36±9.94 N and 43.67±10.27 N. Immediately after treatment, VAS was 2.27±1.27 and 4.44±2.13; threshold was 61.2±12.16 N and 45.0±9.17 N. Authors report between-group differences after treatment (Mann–Whitney, p<0.05), without exact p-values or effect estimates. Within-group change was significant for treated participants (Wilcoxon, p<0.05) and nonsignificant for control. Within-group tests do not replace the between-group test.
No participant reportedly withdrew due to side effects. Structured adverse-event counts or surveillance results are not described; this is not proof of zero harms.
Authors note sex imbalance, restricted age distribution, single rather than double blinding (examiner knew group), missing disease-duration data and only immediate post-treatment assessment. The study cannot establish duration or broad generalizability. Table 1 is an image in the raw XML and unavailable for visual inspection; group characteristics were taken from narrative text. Figure image assets were unavailable locally.
This study reports short-term changes in two pain-related measures after four sessions. It did not assess long-term persistence, everyday function or comparison with medication or exercise.
Authors call for larger, more diverse samples, later follow-up and comparison with medication, exercise and other treatments; they also suggest mechanistic studies.
Read the original article.
Extracorporeal shock wave therapy in myofascial pain syndrome of upper trapezius.
Ji HM, Kim HJ, Han SJ. · Annals of rehabilitation medicine · 2012
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →